FDA nominee Overton dodges questions on Trump influence
Trump's FDA nominee Heidi Overton was quizzed on a range of issues at her Senate hearing, including vaccines, the abortion pill, and agency reforms.
Newsletters and Deep Dive digital magazine
Trump's FDA nominee Heidi Overton was quizzed on a range of issues at her Senate hearing, including vaccines, the abortion pill, and agency reforms.
The infiltration of Australia's Medicare by an AI agent raises serious questions about patient privacy and the security of confidential pharma data.
Europe's top pharma firms have called on governments to take action to change the region's story from one of decay to one of "renewal and resilience."
GLP-1 treatments have historically had an exit problem, as appetite suppression stops when the medication stops.
The NIHR has revealed the first £45m in funding for projects that can bridge the translation gap in healthcare, focusing initially on community care.
Editor's Picks
Newsletters and Deep Dive
digital magazine